Physician

Jasleen Kaur Randhawa, M.D

According to 2025 Medicare claims, Jasleen Randhawa, M.D (NPI: 1134305675) practices hematology/oncology in the Fond du Lac, WI market, with the plurality of this provider's patient population coming from Fond Du Lac, WI. This provider's primary affiliated billing organization is AGNESIAN HEALTHCARE INC (NPI: 1730162991; TIN: 390807236) and primary practice location at 53963-1702. Randhawa is affiliated with the Houston Methodist Coordinated Care (ACO ID: A3473) and SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Randhawa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 126 traditional Medicare patients, billed 9,682 HCPCS/CPT codes, and received $196,771 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 909 prescription claims across 121 beneficiaries totaling $3,734,290 in drug costs, led by Revlimid (Lenalidomide). DME data shows 48 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $11,311 to $196,771. Similarly, Part D prescription costs have moved sharply higher in recent years, from $69,047 to $3,734,290. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,294 to $2,605.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	52	140	$11,311
2016	103	1,109	$33,246
2017	89	527	$25,145
2018	85	559	$49,823
2019	105	448	$39,689
2020	96	485	$44,017
2021	148	19,797	$407,109
2022	131	47,502	$1,094,966
2023	121	68,781	$1,272,409
2024	126	9,682	$196,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	114	$69,047
2016	44	355	$595,318
2017	35	206	$473,830
2018	67	448	$630,415
2019	52	446	$944,608
2020	49	442	$1,433,186
2021	83	430	$1,492,535
2022	103	790	$3,226,028
2023	106	950	$2,950,583
2024	121	909	$3,734,290

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	111	$518,558
2020	N/R	44	$285,315
2021	N/R	11	$479
2022	N/R	135	$9,341
2023	N/R	144	$9,898
2024	N/R	48	$1,751

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	28	28	$133
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	60	142	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	109	259	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	34	959	$634,498
Pomalyst	Pomalidomide	28	784	$601,405
Calquence	Acalabrutinib Maleate	34	1,020	$435,257
Venclexta	Venetoclax	31	920	$272,412
Jakafi	Ruxolitinib Phosphate	13	390	$224,792

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	12	$1,036
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$260
J9190	Injection, fluorouracil, 500 mg	N	N/R	12	$247
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$22	Medline Industries LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jasleen Kaur Randhawa, M.D?

Tedicare shows public-source Medicare data for Jasleen Kaur Randhawa, M.D (NPI 1134305675), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jasleen Kaur Randhawa, M.D have ACO affiliation data?

Jasleen Kaur Randhawa, M.D is shown with ACO affiliation data for Houston Methodist Coordinated Care (MSSP, ACO ID A3473) and SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Jasleen Kaur Randhawa, M.D?

Jasleen Kaur Randhawa, M.D is linked to AGNESIAN HEALTHCARE INC (billing NPI 1730162991) in the available physician profile data.

Does Jasleen Kaur Randhawa, M.D have Open Payments data?

Jasleen Kaur Randhawa, M.D has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.